Accuri C6 Flow Cytometer System
Originally published online as doi:10.1189/jlb.1107768 on July 8, 2008

Published online before print July 8, 2008
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
jlb.1107768v1
84/3/644    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Varga, G.
Right arrow Articles by Sunderkoetter, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Varga, G.
Right arrow Articles by Sunderkoetter, C.
(Journal of Leukocyte Biology. 2008;84:644-650.)
© 2008 by Society for Leukocyte Biology

Glucocorticoids induce an activated, anti-inflammatory monocyte subset in mice that resembles myeloid-derived suppressor cells

Georg Varga*,{dagger},1, Jan Ehrchen*,{dagger},1, Athanasios Tsianakas*,{dagger}, Klaus Tenbrock*,{ddagger}, Anke Rattenholl{dagger}, Stephan Seeliger{ddagger}, Matthias Mack§, Johannes Roth*,{ddagger} and Cord Sunderkoetter*,{dagger},2

* Institute of Immunology and Departments of
{dagger} Dermatology and
{ddagger} Pediatrics, University of Muenster, Muenster, Germany; and
§ Department of Internal Medicine II, University Hospital of Regensburg, Regensburg, Germany

2 Correspondence: Department of Dermatology, University of Muenster, Von Esmarch Str. 58, Muenster D-48149, Germany. E-mail: cord.sunderkoetter{at}ukmuenster.de

ABSTRACT

Glucocorticoids (GC) are still the most widely used immunosuppressive agents in clinical medicine. Surprisingly, little is known about the mechanisms of GC action on monocytes, although these cells exert pro- and anti-inflammatory effects. We have shown recently that GC induce a specific monocyte phenotype with anti-inflammatory properties in humans. We now investigated whether this also applies for the murine system and how this subset would relate to recently defined murine subtypes. After treatment with dexamethasone for 48 h, monocytes up-regulated scavenger receptor CD163 and Gr-1, down-regulated CX3CR1, and shared with human GC-treated monocytes functional features such as low adhesiveness but high migratory capacity. They specifically up-regulated anti-inflammatory IL-10, but not TGF-β, and in contrast to their human counterparts, they down-regulated IL-6. Although GC-induced monocytes down-regulated CX3CR1, a distinctive marker for classical/proinflammatory human and murine monocytes (CX3CR1loCCR2+Ly6Chi), they differed from this physiologically occurring subset, as they remained Ly6Cmed and unactivated (CD62 ligand++). In addition to their immunosuppressive effects, they were CD11b+Gr-1+ and expressed the IL-4R{alpha} chain (CD124), a recently described, signature molecule of tumor-induced myeloid-derived suppressor cells (MDSC). We therefore generated murine MDSC in B16 melanoma-bearing mice and indeed found parallel up-regulation of CD11b+Gr-1+ and CD124 on GC-induced monocytes and MDSC. These data allow us to speculate that the GC-induced subtype shares with inflammatory monocytes the ability to migrate quickly into inflamed tissue, where they, however, exert anti-inflammatory effects and that similarities between GC-induced monocytes and MDSC may be involved in progression of some tumors observed in patients chronically treated with GC.

Key Words: IL-10 • CD124




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
R. D. Stout, S. K. Watkins, and J. Suttles
Functional plasticity of macrophages: in situ reprogramming of tumor-associated macrophages
J. Leukoc. Biol., November 1, 2009; 86(5): 1105 - 1109.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Nagaraj, M. Collazo, C. A. Corzo, J.-I. Youn, M. Ortiz, D. Quiceno, and D. I. Gabrilovich
Regulatory Myeloid Suppressor Cells in Health and Disease
Cancer Res., October 1, 2009; 69(19): 7503 - 7506.
[Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
J. M. Ehrchen, C. Sunderkotter, D. Foell, T. Vogl, and J. Roth
The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer
J. Leukoc. Biol., September 1, 2009; 86(3): 557 - 566.
[Abstract] [Full Text] [PDF]